Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PLCE1 contributors: mct/npt - updated : 28-12-2020
HGNC name phospholipase C, epsilon 1
HGNC id 17175
Corresponding disease
NPHS3 childhood nephrotic syndrome 3
SRN3 steroid-resistant nephrotic syndrome 3
Location 10q23.33      Physical location : 95.753.745 - 96.088.146
Synonym name
  • pancreas-enriched phospholipase C
  • nephrosis type 3
  • phosphoinositide-specific phospholipase C epsilon-1
  • Synonym symbol(s) KIAA1516, RP11-76P2.1, FLJ23659, NPHS3, PLCE, MGC167842, PLC-epsilon-1
    EC.number 3.1.4.11
    DNA
    TYPE functioning gene
    STRUCTURE 338.89 kb     33 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    MAPPING cloned Y linked N status provisional
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    31 - 6516 - 1994 - 2019 31383001
    33 - 12481 - 2302 - 2019 31383001
    33 - 12433 - 2286 - 2019 31383001
    EXPRESSION
    Type widely
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Cardiovascularheart   highly
    Digestiveintestinesmall intestine  highly
    Nervousbrain    
    Reproductivefemale systemplacenta  highly
    Respiratoryrespiratory tracttrachea  highly
    Urinarykidneynephronrenal capsuleglomerulushighly Homo sapiens
    cells
    SystemCellPubmedSpeciesStageRna symbol
    Urinarypodocyte Homo sapiens
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    physiological period embryo
    Text in developing glomerular podocytes
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • N-terminal guanine exchange factor (RAS-GEF) domain, followed by central catalytic X and Y domains
  • a regulatory C2 domain
  • an EF-hand domain
  • a PI-PLC x-box domain
  • a PI-PLC y-box domain
  • two C-terminal HRAS-associating (RA) domains (RA1 and RA2), RA2 domain, in a mode specific to PLCE, having a role in membrane targeting with further regulatory impact on PLC activity (Bunney 2006)
  • HOMOLOGY
    interspecies homolog to rattus Plce1
    homolog to murine Plce1
    Homologene
    FAMILY
  • phospholipase family
  • CATEGORY enzyme
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm,organelle,Golgi
    intracellular,cytoplasm,cytosolic
    basic FUNCTION
  • initiating a cascade of intracellular responses that result in cell growth and differentiation and gene expression
  • required for cell growth
  • has an oncogenic role in skin and intestinal carcinogenesis through inflammation signaling pathways, and in head and neck squamous cell carcinoma progression by binding Ras family small GTPases
  • crucial podocyte protein, highly expressed in embryonic and mature glomeruli, which catalyzes the hydrolysis of phosphatidylinositol-4,5-bispohosphate and generates the second messengers inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG) (Machuca 2009)
  • might regulate cell growth, differentiation, apoptosis and angiogenesis
  • may be involved in the development of sporadic colorectal cancer through its inhibitory effect on cell proliferation
  • essential roles of PLCE1 in esophageal carcinoma cells
  • PLCE1 also plays a role in the proliferation and differentiation of podocytes, regardless of the presence of NCK2
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interacting with IQGAP1
  • interacting with BRAF (Chaib 2008)
  • redundant role of PLCE1-mediated TRPC6 activation at least in podocytes
  • AVIL colocalized and interacted with the phospholipase enzyme PLCE1 and with the ARP2/3 actin-modulating complex
  • PLCE1 regulates Rho GTPase activity and cell migration through interacting with NCK2
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) SRN3 , NPHS3
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --low  
    lower in hepatocellular carcinoma (HCC) cell lines than normal liver epithelial cells and significantly associated with poorer overall survival
    tumoral     --low  
    in 42p100 of colorectal cancer tissues compared with pair-matched normal tissues
    Susceptibility
  • to gastric adenocarcinoma and esophageal squamous cell carcinoma
  • to dengue shock syndrome
  • Variant & Polymorphism other
  • variant assoiciated to risk of gastric adenocarcinoma and esophageal squamous cell carcinoma
  • variant increasing susceptibility for dengue shock syndrome
  • Candidate gene
    Marker
  • may function as a promising biomarker for HCC prognosis
  • Therapy target
    SystemTypeDisorderPubmed
    cancerdigestiveoesophagus
    targeting PLCE1 and its downstream molecules could be effective therapies for esophageal cancer
    ANIMAL & CELL MODELS